2020 - IRIS CAPITAL INVESTMENT

22 Dec 20

Cerinnov Group announces the implementation of an equity line of an amount of €2 million

Cerinnov Group (code ISIN : FR0013178712 – mnémo : ALPCV), spécialiste de l’ingénierie robotique et des équipements industriels pour l’industrie de la céramique et du verre en France et à l’international, annonce ce jour la mise en place d’un financement en fonds propres d’un montant nominal maximum de 2…

28 Jul 20

Polyphor Strengthens financial flexibility with CHF 19.3 million equity-linked financing

Polyphor AG (SIX: POLN) today announced that it has entered into an equity-inked financing arrangement with the French company IRIS to raise a gross amount of up to CHF 19.3 million over the period of two years. IRIS will receive Polyphor shares to be created from the Company’s conditional…

09 Jul 20

Theranexus implements a Mandatory Convertible Bond facility

THERANEXUS ANNOUNCES ITS CASH POSITION AS OF 30 JUNE 2020 ANDIMPLEMENTATION OF A MANDATORY CONVERTIBLE BOND FACILITY • Pro forma cash of €13.3 M at 30 June 2020• Implementation of financing for a maximum total of €4.2 million over 12 months through the issuance of warrants to subscribe mandatory convertible…

29 Apr 20

Bone Therapeutics secures EUR 11 million financing

Gosselies, Belgium, 29 April 2020, 7am CET – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone diseases, today announces that it secured EUR 11.0 million financing. The financing will be used to advance both of its key…

08 Apr 20

Santhera Enters into Equity-linked Financing to Provide up to CHF 12 million with the Option to Increase to up to CHF 24 million

Santhera Enters into Equity-linked Financing to Provide up to CHF 12 million with the Option to Increase to up to CHF 24 million Pratteln, Switzerland, April 8, 2020 – Santhera Pharmaceuticals (SIX: SANN) announces that it has entered into an equity-linked financing arrangement with IRIS (France) in the initial gross…

Year: 2020

Cerinnov Group announces the implementation of an equity line of an amount of €2 million

Polyphor Strengthens financial flexibility with CHF 19.3 million equity-linked financing

Theranexus implements a Mandatory Convertible Bond facility

Bone Therapeutics secures EUR 11 million financing

Santhera Enters into Equity-linked Financing to Provide up to CHF 12 million with the Option to Increase to up to CHF 24 million

Links